Energy storage and carrier materials of the next generations Dr. Tarek Lutz Group Leader Center for Nanoanalytics +49 7121 51530-900 E-Mail anzeigen Prof. Dr. Jannik C. Meyer Bridge Professor Center f
The clinical phases of drug development are characterized by high failure rates of newly developed compounds and associated high costs. This can be remedied by new methods for the design of new active
Non-small cell lung cancer (NSCLC), the most common form of lung cancer at approximately 85%, shows a high tendency to develop resistance to chemotherapeutic agents, resulting in the absence of desire
Compliance at the NMI Compliance with good scientific practice In order to achieve successful results, good scientific practice is required. This includes basic details such as design of experiments,
Disease Models and Mechanisms Non-infectious diseases and their specific pathologies are triggered by defects in molecular and/or cellular processes. Understanding the disease etiology is fundamental
Mechanisms of CNS Diseases Dr. Frank Weise Group Leader Cellular & Molecular Biology +49 7121 51530-56 E-Mail anzeigen Deciphering disease mechanisms and drug development for the central nervous syste
DigiWest® - High Content Protein Profiling Dr. Markus Templin Group Leader Cellular & Molecular Biology +49 7121 51530-828 E-Mail anzeigen DigiWest® is an advanced multiplex protein profiling service
Patch Clamp Dr. Timm Danker Group Leader Electrophysiology +49 7121 51530-896 E-Mail anzeigen Manual and automated patch-clamp, the gold standard in electrophysiology Your advantage is our expertise i
NMI scientist Simon Straß is currently at the 76th Mosbach Colloquium, which this year is entitled “AI-driven (r)evolution in structural biology & protein design”. NMI scientist Simon Straß is current
